Chemoinformaics analysis of Demethylwedelolactone
| Molecular Weight | 300.222 | nRot | 0 |
| Heavy Atom Molecular Weight | 292.158 | nRig | 21 |
| Exact Molecular Weight | 300.027 | nRing | 4 |
| Solubility: LogS | -3.848 | nHRing | 2 |
| Solubility: LogP | 2.571 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 17 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 20 |
| nHA | 7 | APOL | 35.9983 |
| nHD | 4 | BPOL | 12.3657 |
| QED | 0.29 |
| Synth | 2.802 |
| Natural Product Likeliness | 1.51 |
| NR-PPAR-gamma | 0.953 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.766 |
| HIA | 0.198 |
| CACO-2 | -5.153 |
| MDCK | 0.000008 |
| BBB | 0.007 |
| PPB | 0.898776 |
| VDSS | 0.706 |
| FU | 0.159602 |
| CYP1A2-inh | 0.983 |
| CYP1A2-sub | 0.239 |
| CYP2c19-inh | 0.045 |
| CYP2c19-sub | 0.048 |
| CYP2c9-inh | 0.59 |
| CYP2c9-sub | 0.874 |
| CYP2d6-inh | 0.232 |
| CYP2d6-sub | 0.258 |
| CYP3a4-inh | 0.183 |
| CYP3a4-sub | 0.04 |
| CL | 10.086 |
| T12 | 0.898 |
| hERG | 0.007 |
| Ames | 0.355 |
| ROA | 0.037 |
| SkinSen | 0.932 |
| Carcinogencity | 0.033 |
| EI | 0.941 |
| Respiratory | 0.074 |
| NR-Aromatase | 0.844 |
| Antiviral | Yes |
| Prediction | 0.604357 |